Phase 4 Hepatitis Clinical Trials
26 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–20 of 26 trials
Recruiting
Phase 4
SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus
Chronic Hepatitis B
Chinese University of Hong Kong412 enrolled1 locationNCT06364930
Recruiting
Phase 4
Sofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During Pregnancy
Hepatitis C, ChronicPregnancy; Infection
Catherine Anne Chappell100 enrolled9 locationsNCT05140941
Recruiting
Phase 4
Resmiterom Efficacy & Safety in Patients With MASH
MASH - Metabolic Dysfunction-Associated Steatohepatitis
Nabiqasim Industries (Pvt) Ltd165 enrolled1 locationNCT07249788
Recruiting
Phase 4
National Liver Cancer Screening Trial
Liver CancerCarcinoma, HepatocellularLiver Cirrhosis+1 more
University of Texas Southwestern Medical Center5,500 enrolled18 locationsNCT06084234
Recruiting
Phase 4
Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV Donors
Hepatitis B Virus (HBV)Lung Transplant Recipient
University Health Network, Toronto20 enrolled1 locationNCT07189377
Recruiting
Phase 4
Peginterferon Treatment Study for Inactive Chronic Hepatitis B Patients
Hepatitis B, Chronic
Third Affiliated Hospital, Sun Yat-Sen University5,000 enrolled1 locationNCT05182463
Recruiting
Phase 4
Cessation of Long Term NAs vs. Keeping on NAs Among CHB Patients (CNAVK)
Chronic Hepatitis B
Humanity & Health Medical Group Limited2,000 enrolled1 locationNCT03792919
Recruiting
Phase 4
HBV Vaccination of Healthy Volunteers to Evaluate the Composition of Germinal Centers
Hepatitis B
Rockefeller University12 enrolled1 locationNCT05272735
Recruiting
Phase 4
Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B
Hepatitis BViral Hepatitis
Taichung Veterans General Hospital140 enrolled1 locationNCT03933384
Recruiting
Phase 4
Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis
Hepatitis BCirrhosis, LiverChronic Liver Disease
Mercy Medical Center200 enrolled1 locationNCT04588077
Recruiting
Phase 4
Safety and Efficacy of Decentralized HCV Treatment vs Standard-of-Care in Rio de Janeiro (Brazil)
Hepatitis C
Oswaldo Cruz Foundation30,000 enrolled2 locationsNCT06306300
Not Yet Recruiting
Phase 4
Evaluating the effect of Dapagliflozin on Alanine Transaminase Levels in Type 2 Diabetic Patients with Non Alcoholic Fatty Liver Disease
Non Alcoholic SteatohepatitisType 2 Diabetes Mellitus
MTI Lady Reading Hospital192 enrolled1 locationACTRN12624000039583
Not Yet Recruiting
Phase 4
An efficacy study of combined oral doses of glecaprevir/pibrentasvir and sofosbuvir for 16 weeks in hepatitis C patients with documented NS5A resistance who did not respond to previous treatment
Hepatitis C
Auckland District Health Board75 enrolled1 locationACTRN12620000794909
Not Yet Recruiting
Phase 4
Prisons evaluation of a one-stop-shop InterVentiOn to scale-up hepatitis C testing and Treatment: the PIVOT study
Hepatitis C
University of New South Wales720 enrolled1 locationACTRN12619001489189
Completed
Phase 4
Tenofovir Alafenamide (TAF) Breast Milk Pharmacokinetics (PK) study
hepatitis B infection
South Western Sydney Local Health District10 enrolled2 locationsACTRN12619000419167
Terminated
Phase 4
A study of therapy for hepatitis C in pregnancy
PregnancyHepatitis C
Monash Health10 enrolled2 locationsACTRN12619000054112
Completed
Phase 3Phase 4
Fixed twelve weeks duration versus response tailored course of dual Sofosbuvir/Daclatasvir therapy in Egyptian adult and adolescent patients with chronic hepatitis C infection (HCV).
chronic virus hepatitis C infection
Green CRC130 enrolled1 locationACTRN12617000263392
Active
Phase 4
A randomized controlled trial to study whether telbivudine can prevent virus reactivation and improve the prognosis after liver resection in patients with hepatitis B virus-related hepatocellular carcinoma
hepatitis B virus-related hepatocellulcar carcinoma
ZHOU Wei-ping200 enrolled1 locationACTRN12614001224617
Recruiting
Phase 4
Asses the safety and efficacy of switching to tenofovir and lamivudine therapy in patients who have been receiving Hepatitis B Immunoglobulin and lamivudine prophylasix post liver transplant.
prevent Hepatitis B virus re-infection following liver transplantation with the use of tenofovir and lamivudine, withdrawing HBIG.
Professor Peter Angus40 enrolled1 locationACTRN12611001236987
Completed
Phase 4
Treatment of recently acquired hepatitis C infection study
Hepatitis C
The University of New South Wales (acting through the Kirby Institute, formerly the National Centre in HIV Epideiology and Clinical Research))120 enrolled7 locationsACTRN12611000513910